Pfizer Buys King Pharmaceuticals

Pfizer Buys King Pharmaceuticals
Pfizer agreed to buy King Pharmaceuticals the world's 39th largest pharmaceutical company, is based in Bristol, Tennessee for $3.6 billion in cash.Under the terms of the agreement, Pfizer will begin a tender offer in which it will pay $14.25 a share in cash, a 40 percent premium to King Pharmaceuticals’s Monday closing stock price.

Through the deal, Pfizer expects to increase its exposure to the pain medication market, a business that is expected to grow as the population ages. King focuses on making pain drugs that have mechanisms designed to prevent abuse.

King produces a wide range of pharmaceuticals, including Altace for heart attack prevention, Levoxyl for hypothyroidism, Sonata, a sleeping aid, and Skelaxin, a muscle relaxant. King Pharmaceuticals currently operates manufacturing facilities in Bristol, Tennessee, Rochester, Michigan, St. Louis, Missouri, St. Petersburg, Florida, and Middleton, Wisconsin.

Comments

Popular posts from this blog

Jeffrey Jones Sex Offender

STATEMENT

Walmart Black Friday 2010 Ads